ITOS Crosses Above Average Analyst Target
March 03, 2021 at 09:04 AM EST
In recent trading, shares of iTeos Therapeutics Inc (ITOS) have crossed above the average analyst 12-month target price of $43.60, changing hands for $44.20/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..